FEBS Letters · 1985 · 51 citations · 10 references
Life SciencesBiochemistryCellular PharmacologyHypersensitivityInflammationEicosanoid BiosynthesisEosinophilic DisordersEosinophil PhysiologyEosinophil-mediated InflammationLeukotriene BiosynthesisLeukotriene MediatorsLeukotriene ProductionLeukotriene-mediated Inflammation
Purified human eosinophils were challenged with N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4, platelet-activating-factor, valyl-glycyl-seryl-glutamic acid, phorbol myristate acetate, zymosan, opsonized zymosan and the calcium ionophore A23187 to induce leukotriene synthesis. Reversed-phase high performance liquid chromatography analysis demonstrated the almost exclusive synthesis of leukotriene C4 by eosinophils of 11 healthy donors after challenge with opsonized zymosan [(22 +/- 4) X 10(6) molecules LTC4/cell, mean +/- SE] or the calcium ionophore A23187 [(54 +/- 7) X 10(6) molecules LTC4/cell, mean +/- SE]. The other agents were not capable of inducing leukotriene formation. When in addition to opsonized zymosan N-formyl-methionyl-leucyl-phenylalanine or platelet-activating factor were added a significant increase of the leukotriene C4 synthesis by eosinophils was observed. These results suggest that eosinophils might be triggered to produce considerable amounts of the spasmogenic leukotriene C4 in vivo by C3b- and/or IgG-mediated mechanisms e.g. phagocytosis.
10
Peter F. Weller, C W Lee, Donald W. Foster et al. · Proceedings of the National Academy of Sciences · 1983 · 484 citations · Full text
Preferential generation of leukotriene C4 by human eosinophils.
R.J. Shaw, Oliver Cromwell, A. B. Kay · PubMed · 1984 · 133 citations
Immunobiology of the eosinophil.
Takeshi Yoshida, Motomichi Torisu · 1983 · 115 citations
Specific leukotriene formation by purified human eosinophils and neutrophils
Jan Verhagen, P.L.B. Bruynzeel, J A Koedam et al. · FEBS Letters · 1984 · 111 citations · Full text